Table 6.
Summary results for Atripla versus Stribilda
| Cost
|
Survival (years)
|
QALY
|
ICER (LY) | ICER (QALY) | ||||
|---|---|---|---|---|---|---|---|---|
| Lifetime | Δ | Lifetime | Δ | Lifetime | Δ | |||
| Atripla™ | $726,728 | 16.8436 | 14.9565 | |||||
| Stribild® | $733,615 | $6,886 | 16.8625 | 0.0188 | 14.9979 | 0.0414 | $365,750 | $166,287 |
Notes:
a
Incorporating 3% annual discount rate for cost, LY, and QALY outcomes. All costs are reported in 2012 US dollars. All values are per person and rounded.
Abbreviations: ICER, incremental cost-effectiveness ratio; LY, life year; QALY, quality-adjusted life year.